FGF23 and left ventricular hypertrophy: Higher serum FGF23 had also been reported to mediate cardiovascular pathologies, including left ventricular hypertrophy, cardiac fibrosis, and vascular calcification (Böckmann et al., 2019; Faul et al., 2011; Hao et al., 2016; Jimbo et al., 2014).